OrbiMed
W. Carter Neild, CFA, is a General Partner of OrbiMed. Mr. Neild joined OrbiMed in 2002 and has led the firm's expansion into areas such as healthcare royalty investments and Asia. Mr. Neild was previously a Director of the UBS Alternative Investments Group. Prior to his tenure at UBS, he spent four years in the investment management division of First Chicago, now part of J.P. Morgan. Mr. Neild received an M.B.A. in Finance from the University of Chicago, a B.A. in Economics from Emory University, and a C.E.P. from the Institute D’Etudes Politiques in Paris. He received the CFA charter in 1995. Mr. Neild is a member of the Rockefeller University Council.
This person is not in the org chart
This person is not in any offices
OrbiMed
1 followers
From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives. They have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Their team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.